OTC Private Label, Health Home Testing Diagnostic - Business for Sale
Request Information
The contact information for this deal is locked. If you wish to unlock this information, you need to upgrade to SMB Deal Hunter Pro.
🧪
Private-Label Home Diagnostic Testing Kits Company in US
US
Added 1 year ago
Healthcare, Medical, & Fitness
16 years in business
A US-based company is spinning off a new entity focused on private-label home diagnostic testing kits, including pregnancy, ovulation, drug tests, and a COVID-19/Flu test, leveraging an existing distribution network in the healthcare and home products sector.
Key Information
Asking
–
Revenue
$5.9M
Earnings
–
Multiple
–
Key Highlights
- Business operates in the OTC private label health home testing diagnostic kits sector
- Founded in 2009; 16 years established
- NEWCO spinoff will focus on six home testing products: Early Detection Pregnancy test, Digital Pregnancy Rapid Test, Ovulation Kit, Drugs of Abuse Tests (1 Drug and 6 Drug Oral Test Kits), and COVID-19 & FLU A+B Home Multi Test
- Historic revenues for Home Testing Kits: $984,035 in 2023 and $836,043 in 2024
- Top three customers (CVS, 7-Eleven, Army/Air Exchange) have executed purchase orders totaling approximately $2.5 million for Home Testing Kits, going live in May, June, and August 2025
- Transaction involves selling 70-75% ownership in NEWCO at a $6 million valuation, with an earnout structure; excludes cash, accounts receivable, and working capital
Contact Info
Unlock Premium Features
Get everything you need to find, finance, and acquire your business
Personalized Deal Flow
On and off market deals curated to your search criteria.
Unlimited 1:1 M&A Support
Expert advisors to help you spot red flags, negotiate your offer, and hand hold you all the way to close.
Pre-Vetted Deal Team
- * Intros to our preferred lenders
- * Access to our investor community
- * Discounted 3rd party Financial and Legal diligence